[Value of dihydroergotamine-Sandoz in phlebology].
D004087:Dihydroergotamine / Q000009:adverse effects / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D014652:Vascular Diseases / Q000188:drug therapy*; D014680:Veins / Q000187:drug effects
D004087:Dihydroergotamine
Interèt de la dihydroergotamine-Sandoz en phlebologie.